Pharmacoeconomics-Open

Scope & Guideline

Elevating Understanding of Cost-Effectiveness in Medicine

Introduction

Explore the comprehensive scope of Pharmacoeconomics-Open through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Pharmacoeconomics-Open in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2509-4262
PublisherSPRINGER INT PUBL AG
Support Open AccessYes
CountrySwitzerland
TypeJournal
Convergefrom 2017 to 2024
AbbreviationPHARMACOECON-OPEN / Pharmacoecon.-Open
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGEWERBESTRASSE 11, CHAM CH-6330, SWITZERLAND

Aims and Scopes

Pharmacoeconomics-Open is dedicated to advancing the field of pharmacoeconomics and health economics through rigorous analysis and evaluation of healthcare interventions. The journal emphasizes the importance of economic evaluations in informing healthcare decision-making and policy formulation.
  1. Cost-Effectiveness Analysis (CEA):
    The journal publishes extensive research on cost-effectiveness analyses of various healthcare interventions, including pharmaceuticals, medical devices, and treatment protocols, providing a comprehensive understanding of their economic value.
  2. Health Technology Assessment (HTA):
    Pharmacoeconomics-Open focuses on health technology assessments that evaluate the clinical efficacy, safety, and economic implications of new treatments and technologies, guiding stakeholders in healthcare decision-making.
  3. Budget Impact Analysis (BIA):
    The journal includes studies on budget impact analyses, evaluating the financial implications of adopting new therapies or technologies within specific healthcare systems, aiding in resource allocation and policy planning.
  4. Patient-Centered Outcomes:
    Research highlighting patient-reported outcomes and quality of life assessments is central to the journal's scope, emphasizing the importance of patient perspectives in evaluating healthcare interventions.
  5. Methodological Innovations in Economic Evaluation:
    Pharmacoeconomics-Open encourages submissions that explore new methodologies in economic evaluation, including modeling techniques and statistical approaches, to enhance the rigor and applicability of pharmacoeconomic studies.
Pharmacoeconomics-Open is witnessing emerging themes that reflect the evolving landscape of healthcare economics and the increasing complexity of healthcare interventions. These trends highlight the journal's responsiveness to contemporary challenges and innovations in the field.
  1. Integration of Artificial Intelligence (AI):
    Recent publications emphasize the role of AI in automating health economic modeling and decision-making processes, showcasing innovative applications that enhance efficiency and accuracy in economic evaluations.
  2. Real-World Evidence (RWE):
    There is a growing trend towards incorporating real-world evidence in economic evaluations, with studies focusing on the effectiveness and cost implications of interventions in routine clinical practice, rather than controlled trial settings.
  3. Value-Based Healthcare Models:
    Emerging research emphasizes value-based healthcare approaches that assess treatments based on their outcomes relative to costs, reflecting a shift in focus from volume-based care to value-driven systems.
  4. Patient-Centered and Multi-Criteria Decision Analysis:
    An increasing number of studies are employing multi-criteria decision analysis (MCDA) frameworks that incorporate diverse stakeholder preferences, including patient values, in the evaluation of healthcare interventions.
  5. Global Health Economics:
    The journal is seeing a rise in submissions addressing global health economics, particularly in low- and middle-income countries, highlighting unique challenges and opportunities in these contexts.

Declining or Waning

While Pharmacoeconomics-Open continues to thrive in many areas, certain themes appear to be waning in prominence over the recent years. This decline may reflect shifts in research focus or changing priorities in healthcare economics.
  1. Traditional Cost-Utility Analysis:
    There is a noticeable decline in the frequency of traditional cost-utility analyses focusing solely on generic health states, as researchers increasingly adopt more nuanced approaches that incorporate broader patient-reported outcomes.
  2. Single-Condition Focused Studies:
    Research solely centered on specific diseases or conditions, such as individual cancers or chronic illnesses, is becoming less prevalent, with a shift towards studies that consider broader healthcare systems and multiple conditions.
  3. Static Economic Models:
    The use of static economic models that do not account for real-world variability and long-term outcomes is decreasing, as there is a growing preference for dynamic modeling approaches that reflect changing patient populations and treatment landscapes.

Similar Journals

JOURNAL OF HEALTH ECONOMICS

Driving Innovation in Health Economics and Public Policy
Publisher: ELSEVIERISSN: 0167-6296Frequency: 6 issues/year

JOURNAL OF HEALTH ECONOMICS, published by Elsevier, is a leading peer-reviewed journal in the fields of health policy and public health, with an impressive impact factor indicative of its significance in academic research. Since its inception in 1982, the journal has been a pivotal platform for disseminating impactful research that influences health care policies and economic evaluations, addressing critical topics that drive effective health care delivery and resource allocation. With its current ranking of Q1 in both Health Policy and Public Health, Environmental and Occupational Health, it is recognized among the top journals in these areas, boasting a Scopus rank that places it in the top percentiles of health-related publications. Although it operates under a subscription model, researchers and practitioners benefit from its rich repository of studies and analysis that advance knowledge and practice in health economics. The journal remains committed to fostering interdisciplinary dialogue, making it an invaluable resource for researchers, professionals, and students committed to improving health systems and outcomes.

International Journal of Health Economics and Management

Exploring the nexus of economics and health for global impact.
Publisher: SPRINGERISSN: 2199-9023Frequency: 4 issues/year

International Journal of Health Economics and Management is a premier academic journal published by SPRINGER, focusing on innovative research at the intersection of health economics and management practices. Established in 2015, this journal caters to a diverse range of disciplines, integrating rigorous economic analysis with vital health policy discussions. With an impressive impact factor reflective of its influential publications, it holds a distinguished Q1 ranking in Economics, Econometrics, and Finance, and a Q2 ranking in Health Policy for 2023. The journal provides an open access model, enabling wider dissemination of research findings to academics, policymakers, and healthcare professionals globally. Researchers and students alike will find this journal invaluable for its commitment to advancing knowledge in health economics and improving healthcare management practices through empirical studies and theoretical insights. For more information, or to access articles, please refer to the journal's platform.

American Economic Journal-Economic Policy

Transforming Economic Research into Actionable Policies
Publisher: AMER ECONOMIC ASSOCISSN: 1945-7731Frequency: 4 issues/year

American Economic Journal - Economic Policy, published by the American Economic Association, stands at the forefront of economic research, focusing on significant policy implications and evidence-based evaluations. With an ISSN of 1945-7731 and an E-ISSN of 1945-774X, this esteemed journal has maintained its influence and credibility in the field since its inception in 2009. Ranked in the Q1 category for Economics, Econometrics and Finance and ranking #7 out of 288 in Scopus, it boasts a remarkable 97th percentile ranking, making it a premier source for cutting-edge research and policy discussion. The journal's rigorous peer-reviewed articles aim to bridge the gap between academic research and real-world economic policy, serving as an essential resource for researchers, professionals, and students who seek to engage with and contribute to the evolving landscape of economic policy. With open access options not currently available, readers are encouraged to subscribe or access articles through academic institutions for comprehensive insights into the economic challenges and innovations shaping our world.

International Journal of Healthcare Management

Empowering healthcare leaders with cutting-edge insights.
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 2047-9700Frequency: 4 issues/year

The International Journal of Healthcare Management, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, stands as a crucial platform for the dissemination of innovative research and insights in the realm of healthcare management. With a focus on health policy, leadership, and management, this journal aims to bridge the gap between theory and practice, providing a valuable resource for researchers, professionals, and students alike. It boasts an impressive Q2 ranking in Leadership and Management and a Q3 ranking in Health Policy for 2023, highlighting its influence and relevance within the academic community. With an accessible ISSN of 2047-9700 and E-ISSN of 2047-9719, the journal features an array of peer-reviewed articles that promote the advancement of knowledge and best practices in healthcare settings. While currently not offered as open access, the journal publishes high-quality research that underscores the importance of effective management strategies in enhancing healthcare outcomes. Positioned in the United Kingdom, the journal continues to contribute significant knowledge and frameworks that guide healthcare leaders and policymakers in navigating the complexities of governance in health services.

Applied Health Economics and Health Policy

Innovating health solutions through economic evaluation.
Publisher: SPRINGER INT PUBL AGISSN: 1175-5652Frequency: 6 issues/year

Applied Health Economics and Health Policy, published by Springer International Publishing AG, stands as a premier academic journal dedicated to the intersection of economic theory and health policy. With a strong focus on the practical application of economic principles to health issues, this journal addresses crucial topics such as healthcare financing, resource allocation, and economic evaluation of health interventions. Its impressive rankings—in the top quartile for both Health Policy and Medicine, as well as a notable second quartile in Economics—illustrate its significant impact within the fields of health economics and policy research. The journal is aimed at researchers, policymakers, and students who seek to explore innovative solutions to contemporary health challenges. Established in 2002 with ongoing publications through 2024, the journal features open access options that enhance accessibility and engagement with its extensive body of research articles, ensuring that vital insights are available to a global audience.

HEALTH ECONOMICS

Pioneering research that shapes global health economics.
Publisher: WILEYISSN: 1057-9230Frequency: 12 issues/year

HEALTH ECONOMICS is a premier academic journal published by Wiley, dedicated to advancing the field of health economics. With an ISSN of 1057-9230, this journal has been a vital resource since its inception in 1992, and continues to contribute significantly to the academic landscape as it extends its cover to 2024. With a distinguished ranking of Q1 in Health Policy for 2023, it showcases cutting-edge research and theoretical advancements that inform health policy and economic decision-making globally. The journal features rigorous peer-reviewed articles that address a diverse range of topics within health economics, making it an essential platform for researchers, financial analysts, policymakers, and students alike. Although not an Open Access journal, it strives to ensure accessibility of critical insights for a broad audience, further enhancing its influence within the health economics community.

VALUE IN HEALTH

Transforming Insights into Impact for Global Health
Publisher: ELSEVIER SCIENCE INCISSN: 1098-3015Frequency: 12 issues/year

VALUE IN HEALTH, published by Elsevier Science Inc, is a premier peer-reviewed journal in the fields of Health Policy, Medicine, and Public Health. With an impressive impact factor reflecting its respected standing, the journal has achieved a distinguished Q1 classification in multiple categories, placing it among the top publications in the health domain. Since its inception in 1998, this journal has been a vital platform for disseminating research that informs health policy and practice, impacting both clinical and public health decision-making. The journal’s Scopus rankings further underscore its global influence, with notable positions in Medicine and Public Health sectors. VALUE IN HEALTH is committed to fostering an environment where innovative research meets practical application, ultimately aiming to enhance health outcomes worldwide. Researchers, professionals, and students alike are encouraged to explore the wealth of knowledge contained within its pages.

Gesundheitsoekonomie und Qualitaetsmanagement

Fostering Excellence in Health Economics and Quality Management
Publisher: THIEME MEDICAL PUBL INCISSN: 1432-2625Frequency: 6 issues/year

Gesundheitsoekonomie und Qualitaetsmanagement, published by THIEME MEDICAL PUBL INC, serves as a vital resource in the field of health policy, particularly within the context of Germany. Since its inception in 1999, this journal has been committed to advancing the discourse on health economics and quality management, making significant contributions to understanding the complexities of healthcare systems. With an impact factor that reflects its ongoing importance, the journal is categorized in the Q4 quartile for Health Policy as of 2023, indicating its role in serving a niche yet crucial space in medical literature. Although currently not an open access journal, it remains accessible through various academic platforms, making its content available to a diverse audience of researchers, healthcare professionals, and students eager to engage with contemporary issues in health economics. With its publication continuing through 2024, Gesundheitsoekonomie und Qualitaetsmanagement is essential for anyone looking to deepen their understanding of the economic aspects of healthcare and ensure quality management in health services.

Expert Review of Pharmacoeconomics & Outcomes Research

Unlocking the Value of Pharmacoeconomics for Healthcare Progress
Publisher: TAYLOR & FRANCIS LTDISSN: 1473-7167Frequency: 6 issues/year

Expert Review of Pharmacoeconomics & Outcomes Research is a leading journal published by TAYLOR & FRANCIS LTD, focusing on the critical intersection of pharmacoeconomics and healthcare outcomes. Established in 2001, the journal has been a key resource for researchers and professionals in the fields of health policy, medicine, and pharmacology, consistently ranked in the top quartile of these categories for its influential insights. With an ISSN of 1473-7167 and an E-ISSN of 1744-8379, it delivers cutting-edge research that informs healthcare decisions and policy frameworks. The journal's rigorous peer-review process ensures the publication of high-quality, impactful articles that address contemporary challenges and advancements in pharmacoeconomic evaluations. As of 2023, it boasts a commendable ranking of #106 in Health Policy and #124 in Pharmacology, affirming its relevance and contribution to the field. Despite being a subscription-based journal, the strength of its content makes it an invaluable tool for researchers and practitioners aiming to enhance patient outcomes and optimize resource allocation in healthcare systems.

Value in Health Regional Issues

Fostering Multidisciplinary Collaboration in Health Economics.
Publisher: ELSEVIERISSN: 2212-1099Frequency: 3 issues/year

Value in Health Regional Issues, published by Elsevier, is an essential academic journal that addresses critical developments in the field of health economics, policy, and pharmaceuticals. With an impressive impact factor, this journal has established itself as a leading platform for disseminating innovative research, evidenced by its Q1 quartile ranking in Economics, Econometrics and Finance and Pharmacology, Toxicology and Pharmaceutics. Founded in 2012, the journal is dedicated to exploring value-based healthcare, focusing on regional perspectives that highlight economic implications and health outcomes. Covering a convergence of multidisciplinary themes, the journal fosters academic collaboration and provides researchers, professionals, and students with access to high-quality, peer-reviewed articles. As it continues to expand its scope through 2025, Value in Health Regional Issues remains a pivotal resource for those seeking to understand and influence health policy and economic frameworks on a regional, national, and global scale.